AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Clin Nutr 89: 51-57, 2009. First published December 3, 2008; doi:10.3945/ajcn.2008.26802
 American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.26802
Vol. 89, No. 1, 51-57, January 2009
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow All Versions of this Article:
89/1/51    most recent
ajcn.2008.26802v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mutch, D. M
Right arrow Articles by Clément, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mutch, D. M
Right arrow Articles by Clément, K.
Agricola
Right arrow Articles by Mutch, D. M
Right arrow Articles by Clément, K.
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Needle and surgical biopsy techniques differentially affect adipose tissue gene expression profiles1,2,3

David M Mutch, Joan Tordjman, Véronique Pelloux, Blaise Hanczar, Corneliu Henegar, Christine Poitou, Nicolas Veyrie, Jean-Daniel Zucker and Karine Clément

1 From the INSERM, Nutriomique U872 Team 7, Paris, France (DMM, JT, VP, BH, CH, CP, J-DZ, and KC); the Université Pierre et Marie Curie Paris 6, Centre de Recherche des Cordeliers, Paris, France (DMM, JT, VP, BH, CH, CP, J-DZ, and KC); the Université Paris Descartes, Paris, France (DMM, JT, VP, BH, CH, CP, Z-DZ, and KC); the Assistance Publique-Hopitaux de Paris, Nutrition and Endocrinology Department, Pitié-Salpêtrière Hospital, Paris, France (CP and KC); and the Université Paris Descartes, Surgery Department, Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France (NV).

2 Supported by Paris 6 University (Bonus Quality Research) and by the Assistance Publique Hôpitaux de Paris/Direction de la Recherche Clinique (CRC P050318), and a grant from the European Community 7th framework program: ADAPT "Adipokines as Drug Targets to combat Adverse effects of excess ADipose Tissue" project (grant agreement 201100). DMM is funded by the European Community [DiOGenes – Diet, genes and obesity (contract FP6-513946)].

3 Reprints not available. Address correspondence to DM Mutch, University of Guelph, Department of Human Health and Nutritional Sciences, Guelph, ON, Canada N1G 2W1. E-mail: dmutch{at}uoguelph.ca or dmmutch_sci{at}hotmail.com.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Adipose tissue gene expression analysis in humans now provides a tremendous means to discover the physiopathologic gene targets critical for our understanding and treatment of obesity. Clinical studies are emerging in which adipose gene expression has been examined in hundreds of subjects, and it will be fundamentally important that these studies can be compared so that a common consensus can be reached and new therapeutic targets for obesity proposed.

Objective: We studied the effect of the biopsy sampling methods (needle-aspirated and surgical) used in clinical investigation programs on the functional interpretation of adipose tissue gene expression profiles.

Design: A comparative microarray analysis of the different subcutaneous adipose tissue sampling methods was performed in age-matched lean (n = 19) and obese (n = 18) female subjects. Appropriate statistical (principal components analysis) and bioinformatic (FunNet) functional enrichment software were used to evaluate data. The morphology of adipose tissue samples obtained by needle-aspiration and surgical methods was examined by immunohistochemistry.

Results: Biopsy techniques influence the gene expression underlying the biological themes currently discussed in obesity (eg, inflammation, extracellular matrix, and metabolism). Immunohistochemistry experiments showed that the easier to obtain needle-aspirated biopsies poorly aspirate the fibrotic fraction of subcutaneous adipose tissue, resulting in an underrepresentation of the stroma-vascular fraction.

Conclusions: The adipose tissue biopsy technique is an important caveat to consider when designing, interpreting, and, most important, comparing microarray experiments. These results will have crucial implications for the clinical and physiopathologic understanding of human obesity and therapeutic approaches.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
White adipose tissue (AT) is a critical player in obesity-related metabolic functions (1). Indeed, AT is no longer considered to be simply a passive lipid reservoir but rather an endocrine organ capable of secreting factors that profoundly influence processes such as feeding behavior, energy flux, and immunoinflammation. As such, obtaining AT samples is paramount to the understanding of the pathophysiology of human obesity (2, 3). Much of our recent understanding about the role of AT in human obesity is a consequence of using modern molecular biology tools, such as the microarray (4, 5). More specifically, evidence indicates that various inflammatory pathways are activated in obese subcutaneous AT (scAT) and that these same pathways are down-regulated after weight loss (1, 6–9). The described transcriptional profiles in AT are concomitant with variations in immune cell types whose phenotypes and roles are not yet fully elucidated (7, 10–13). Recently, it was postulated that the significant up-regulation of constituents of the extracellular matrix, most notably the enhanced presence of interstitial regions of fibrosis infiltrated with different types of inflammatory cells, may serve to mediate the interactions between local inflammatory events and perturbed AT metabolic functions (7). Although this "fibrotic link" between inflammation and metabolism requires further exploration, evidence that metabolic pathways in obesity are unbalanced was recently reinforced. Pietiläinen et al (1) studied rare monozygotic twin pairs discordant for body weight and provided further evidence of mitochondrial dysfunction in obesity, as shown by the down-regulation of pathways related to branch chain amino acid catabolism, fatty acid synthesis, and β-oxidation in scAT. Taken together, the global analysis of gene expression has shown the pathologic perturbations of AT biology in obese states and the important contribution of AT to obesity-related complications.

A rapidly growing number of studies are now designed to identify new candidate genes and related gene products based on AT gene expression signatures from humans varying in corpulence or whose weight fluctuates in response to environmental stimuli (ie, by modifying diet, physical activity, medical treatment, etc). The accessibility of human AT samples for gene expression analyses has been notably facilitated by the development of obesity surgery programs, thereby enabling laboratories to establish AT bio-banks for large-scale studies. Progress in the analytic platforms, experimental protocols, and analysis of microarrays has seen this technology take significant steps from the bench toward the bedside (5, 14). Multiple examples now exist in which researchers have used this tool to classify and predict diseases and to assess the interindividual variations in response to environmental stresses (15–19). Although many biological and technical limitations still exist (eg, interindividual differences, the quality and quantity of tissue biopsy samples, and analytic sensitivity), steps are being taken to overcome these obstacles to obtain the most relevant and physiologically "accurate" information possible. Indeed, this accuracy can only be achieved if the quality and authenticity of the biological material studied is assured. It is currently unknown whether the different biopsy methods used to obtain AT samples in humans may affect microarray interpretation.

The present study was designed to explore the effect of different scAT biopsy methods on the functional interpretation of gene expression data. The knowledge revealed by this comparison of sampling methods will serve as a caveat for the experimental design of future microarray work in human obesity and will lead to a dramatic improvement in the reproducibility of results and conclusions.


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Subjects and AT samples
The clinical investigations were performed according to the Declaration of Helsinki and were approved by the ethics committees of Hôtel-Dieu Hospital (Paris, France). Informed consent was obtained from all subjects. All tissue biopsies were obtained in the morning from subjects after an overnight fast. Eighteen obese and 19 lean women were prospectively recruited in 2007 for the present study (Table 1). Abdominal subcutaneous fat specimens were obtained by needle aspiration in the periumbilical area under local anesthesia from 9 obese subjects and 10 lean subjects. Surgical abdominal subcutaneous fat biopsies were obtained by a surgeon from 9 obese subjects. The remaining 9 lean subjects had surgical abdominal fat biopsies taken before elective plastic surgery. Lean subjects had no prior history of weight problems. Additional independent subjects [n = 3; average age: 45 ± 5.2 y; average body mass index (BMI; in kg/m2): 53.4 ± 8.1] were recruited in 2008; both surgical and needle-aspirated biopsies were obtained from these subjects at the time of recruitment. These AT samples were used for the morphologic analysis of tissues obtained by the different biopsy methods.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Characteristics for the 4 groups studied1

 
Needle biopsy
This technique has been standardized in accordance with previous work performed within the European Framework 5 project NUGENOB (http://www.nugenob.com/). Superficial subcutaneous AT samples of {approx}1–2 cm3 (corresponding to {approx}1–2 g) were obtained from the periumbilical area, under local anesthesia (1% xylocaine), from a comparable site of the abdomen. A region 5 cm lateral from the umbilicus (either to the left or right side of the abdomen) was sterilized. A half circular small dermal injection (intracutaneous) was made, and 2 mL of a local anesthetic agent was injected. After 5 min, the skin was sterilized again. A needle (BD Microlance Hypodermic Needle, 16 G, 40 mm, regular bevel, part no. 300637; Becton Dickinson France SAS, Le Pont-De-Claix, France) was then adapted to a 20-mL syringe and the piston compressed. Approximately one-third of the length of the needle was inserted into the subcutaneous fat, and the needle piston was released maximally until it was locked by a stopper, thereby creating a vacuum. Tissue resistance was created by the surgeon gripping the abdominal wall with one hand while the other hand rotated the needle throughout the tissue in an up-down motion. Once the tissue was aspirated by the syringe, the needle was withdrawn, and the piston was removed; AT samples were washed in physiologic serum, placed immediately in liquid nitrogen, and stored at –80°C until analysis. Needle-aspirated biopsies that appeared bloody were not used for the present comparative analysis.

Surgical biopsy
This technique has been standardized with the Hôtel-Dieu Hospital surgeons. Subcutaneous superficial AT samples from subjects were obtained by surgical biopsy from the periumbilical area, under local anesthesia (1% xylocaine). First, the skin was cleaned and covered with special surgical drapes. An incision of <0.5 cm was made with a plain scalpel to access the subcutaneous AT. The surgeon held the tissue with atraumatic forceps and cut the tissue pieces with scissors. About 2–3 cm3 (corresponding to {approx}3–5 g) AT was then removed, washed in physiologic serum, placed immediately in liquid nitrogen, and stored at –80°C until analysis. The skin incision was then closed with absorbable suture material.

Sample preparation and microarray analysis
Total RNA was extracted from biopsies with the use of the RNeasy total RNA Mini kit (Qiagen, Courtaboeuf, France). Both needle and surgical biopsy samples were directly homogenized in RLT buffer with the use of a VDI 25 adaptable homogenizer (VWR, Fontenay-sous-Bois, France). Total RNA concentration and quality were confirmed with the use of the Agilent 2100 Bioanalyzer (Agilent Technologies, Massy, France). Total RNA (200 ng) from each sample was amplified and transcribed into fluorescent cRNA with the use of Agilent's Low RNA Input Linear Amplification kit (Agilent Technologies). Cyanine-5 dye was incorporated into all samples, and an in-house obese reference pool was labeled with cyanine-3 dye. In brief, the in-house reference pool was created by mixing equal amounts of total RNA extracted from AT samples of subjects undergoing plastic surgery, as previously described (20). All samples were hybridized to Agilent whole human genome microarrays. These microarrays comprise >41,000 unique 60-mer oligonucleotide human sequences and transcripts. Sample preparation, hybridization, and microarray washing were performed according to the manufacturer's recommendations (Agilent Technologies). Arrays were scanned with the use of a GenePix 4000A Scanner (Axon Instruments-Molecular Devices, Sunnyvale, CA).

AT morphology
Both needle-aspirated and surgical subcutaneous AT biopsies were obtained from the periumbilical area of subjects undergoing gastric surgery. Samples were fixed overnight at 4°C in 4% paraformaldehyde and then embedded in paraffin. Thin sections ({approx}5 µm thickness) were stained with hematoxylin-eosin and examined with a Zeiss 20 Axiostar Plus microscope (Zeiss, Jena, Germany). Digital images were captured with a Sony triCCD camera (Sony, Paris, France). Fibrotic regions were identified by incubating tissue sections in 0.2% phosphomolybdic acid, 0.1% picrosirius red (direct red 80 in saturated picric acid), and 0.01 N HCl and then dried and mounted in Permount (21).

Immunohistochemistry
Immunohistochemical detection of HAM56 (Dako Cytomation, Trappes, France) was performed with the use of the avidin-biotin peroxidase method (22), as previously described (10).

Statistical analysis
For all microarrays, background signal was not subtracted before the Loess normalization of log-transformed microarray data with the use of the Goulphar Version 1.1.3 package (http://transcriptome.ens.fr/goulphar/index.php) (23). Gene lists were filtered to identify genes common to all microarrays with the use of Microsoft Excel (Microsoft, Redmond, WA). Differential gene expression, using a 0.5% false discovery rate (FDR), was assessed with the use of the Significance Analysis of Microarrays (version 3.02) procedure (available at http://www-stat.stanford.edu/tibs/SAM/). Multivariate analysis [hierarchical clustering and principal components analysis (PCA)] was performed with the use of Umetrics SIMCA-P (version 11.0.0.0; Umetrics AB, Umea, Sweden) and TM4 version 4.0 software (http://www.tm4.org/) (24). The functional profiling of gene expression data was performed with the use of FunNet (http://www.funnet.info), which was extensively described elsewhere (7). The complete data set is publicly available at the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) through the series accession number GSE12050.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Subjects for this study were placed into 4 groups according to BMI and biopsy method: Lean-Needle (n = 9), Lean-Surgery (n = 10), Obese-Needle (n = 9), and Obese-Surgery (n = 9). The subjects were matched for age and BMI (Table 1). Microarray data were filtered so that only probe-sets targeting genes identified in the NCBI EntrezGene database were used (ie, known GeneIDs). This represented {approx}32,000 probes of the {approx}45,000 probes present on the microarray platform. Next, we averaged the logarithmic ratios of GeneIDs represented by multiple probe-sets on the microarray so as to have a single value per GeneID per subject. Finally, only probe-sets identified across all 37 microarrays were considered for analyses. This resulted in a final list of 9689 unique GeneIDs. With the use of these 9689 GeneIDs, all subjects were simultaneously analyzed to identify potential outlying data. PCA identified one outlier in the Lean-Surgery group; therefore this subject was removed from all further analyses (Figure 1). Both PCA and hierarchical clustering (by Pearson correlation) showed that subjects were organized into distinct groups, based on BMI and biopsy technique (Figure 1). Despite obtaining the various scAT samples from independent subjects, the tight clustering of the 4 groups illustrated in Figure 1 shows that group differences are considerably more important than interindividual differences. Interindividual differences in gene expression in scAT were previously shown to be low (25), thereby reinforcing the dominant effect of the sampling method on gene expression profiles.


Figure 1
View larger version (21K):
[in this window]
[in a new window]

  		FIGURE 1. Principal components analysis of all subjects. A total of 9689 GeneIDs were in common among all 37 microarrays, where each microarray corresponds to a single subject. One lean surgical subject was considered an outlier and removed from subsequent analyses. The first 2 principal components (PC1 and PC2) explain 30.1% of the variance in the data set. Hierarchical clustering with the use of a Pearson correlation confirmed that subjects cluster according to BMI and biopsy method; Lean-Needle refers to lean subjects having needle biopsies; Lean-Surgery, lean subjects having surgical biopsies; Obese-Needle, obese subjects having needle biopsies; Obese-Surgery, obese subjects having surgical biopsies.

 
Differential gene expression for all pairwise comparisons was determined with a standard analysis of microarray analysis with the use of an FDR of {approx}0.5%. Although the use of an FDR of 0.5% can be considered stringent, we made the choice to adhere to the highest degree of statistical stringency possible so as to achieve the greatest confidence in our biological interpretations. Despite the use of this stringent FDR, the comparisons showed the anticipated highly significant differences between obese and lean subjects, but more astonishingly between needle and surgical biopsy techniques as well. The Obese-Needle compared with Lean-Needle analysis identified 3141 differentially expressed genes and the Obese-Surgery compared with Lean-Surgery analysis identified 3910 differentially expressed genes; however, the Lean-Needle compared with the Lean-Surgery identified 2358 differentially expressed genes and the Obese-Needle compared with the Obese-Surgery identified 3946 differentially expressed genes. Variability in gene expression data sets was equivalent between all 4 groups (see Figure S1 under "Supplemental Data" in the online issue).

Although thousands of genes were identified as differentially regulated between the 2 biopsy techniques, this did not necessarily imply that these gene lists were enriched in biologically meaningful data that could affect data interpretation. Therefore, we performed a functional analysis of these gene lists with the use of the FunNet tool (7) and confirmed results with DAVID Bioinformatics Resources (confirmatory data not shown) (26). KEGG pathways and Gene Ontology Cellular Component annotations were examined to identify those functional annotations that were significantly enriched in the different gene lists. This analysis showed that biological themes commonly discussed in obesity (eg, inflammation, extracellular matrix, and metabolism) are influenced by the biopsy sampling technique; a crucial caveat to consider when designing experiments in humans.

Indeed, the 2 tissue sampling methods had a different effect on the functional interpretation of gene expression data in both lean and obese subjects, indicating that these differences occur independently to changes in body corpulence. The comparison between the Surgery and Needle groups showed that genes involved in KEGG inflammatory pathways (cytokine-cytokine receptor interaction, Fc{epsilon}RI signaling pathway) and in the metabolism of lipids (biosynthesis of unsaturated fatty acids, glycerolipid metabolism, glycerophospholipid metabolism, etc), carbohydrates (glycolysis-gluconeogenesis, starch and sucrose metabolism), and amino acids (valine, leucine, and isoleucine degradation) are not equally represented in the 2 biopsy techniques (Figure 2, A and B). These differences coincided with changes in the Gene Ontology cellular component analysis, in which the membrane and mitochondrial fractions were not equally represented in the 2 biopsy methods (Figure S2, A and B). Therefore, the different biopsy methods will influence the biological interpretation of global gene expression data sets and suggest that it is not appropriate to combine samples obtained by different biopsy techniques within a study.


Figure 2
View larger version (35K):
[in this window]
[in a new window]

  		FIGURE 2. KEGG functional analysis. Up-regulated and down-regulated genes in the different pairwise comparisons were functionally studied to identify pathways enriched in one list compared with the other. The list of 9689 GeneIDs identified in all microarrays was used as the common reference list for all comparative analyses. These comparative analyses used only differentially expressed genes identified with the use of a 0.5% false discovery rate with the Significance Analysis of Microarrays (SAM) analysis. A: Pathways up-regulated (Lean-S > Lean-N) and down-regulated (Lean-S < Lean-N) in surgical biopsies compared with needle-aspirated biopsies from lean subjects. B: Pathways up-regulated (Obese-S > Obese-N) and down-regulated (Obese-S < Obese-N) in surgical biopsies compared with needle-aspirated biopsies from obese subjects. C: Pathways up-regulated (Obese-N > Lean-N) and down-regulated (Obese-N < Lean-N) in obese subjects compared with lean subjects, whereby both groups have had needle-aspirated biopsies. D: Pathways up-regulated (Obese-S > Lean-S) and down-regulated (Obese-S < Lean-S) in obese subjects compared with lean subjects, whereby both groups have had surgical biopsies. Transcriptional domain coverage indicates the most significant biological functions represented among annotated genes, ranked by percentage. Lean-N, lean subjects having needle biopsies; Lean-S, lean subjects having surgical biopsies; Obese-N, obese subjects having needle biopsies; Obese-S, obese subjects having surgical biopsies.

 
We next determined whether similar biological conclusions concerning the obese state could be reached with the use of both needle-aspirated and surgical biopsies. The Obese-Needle and Lean-Needle comparison showed that elements related to inflammation were both up- (eg, natural killer cell–mediated cytotoxicity, and antigen processing and presentation) and down-regulated (eg, cytokine-cytokine receptor interaction, and complement and coagulation cascades) in obese subjects (Figure 2C), whereas the extracellular component was up-regulated (Figure S2C). The only mitochondrial-related KEGG functional pathways identified was oxidative phosphorylation, and the cellular component analysis showed that the mitochondrial fraction was decreased in obese subjects. In contrast, the surgical biopsies provided a more complete overview of the complex biological changes in AT associated with obesity. Indeed, inflammatory (B cell signaling, T cell receptor signaling, Toll-like receptor signaling, etc), cytoskeleton (regulation of actin cytoskeleton), and cellular interaction pathways (cell adhesion molecules) were all up-regulated in obese subjects, whereas metabolic pathways related to lipid (eg, biosynthesis of unsaturated fatty acids and glycerophospholipid metabolism, etc), carbohydrate (starch and sucrose metabolism), and amino acid (eg, valine, leucine, and isoleucine degradation) were down-regulated (Figure 2D), as was the oxidative phosphorylation pathway. As expected, extracellular and membrane-related fractions were up-regulated in obese subjects, and the mitochondrial fraction was down-regulated (Figure S2D).

We therefore hypothesized that the structure and morphology of the tissue samples obtained with the use of these 2 biopsy techniques may provide an explanation for the aforementioned differences in gene expression (Figure 3). With the use of biopsies obtained from the same obese subjects, both biopsy methods maintained the structure of adipocytes (Figure 3, A and B) and were comparable for the study of macrophage infiltration, as shown by the visualization of crownlike structures (Figure 3, C and D) previously observed in scAT (27). However, needle-aspirated scAT biopsies were more fragmented and contained more sanguineous regions on the periphery of adipocyte fractions, thereby increasing blood cell contaminations, in comparison to surgical biopsies. Furthermore, needle-aspirated biopsies had little to no fibrotic regions; in agreement with previous reports in the liver that have shown that the presence of subcapsular fibrosis in wedge (surgical) liver biopsies is greater than with needle-aspirated liver biopsies (28, 29). In contrast, the fibrotic region was intact in surgical scAT biopsies. These morphologic findings were further confirmed with the use of surgical and needle-aspirated tissue samples obtained from another independent group of subjects (n = 3) for whom both scAT tissue samples were simultaneously taken at the time of the surgery (data not shown).


Figure 3
View larger version (126K):
[in this window]
[in a new window]

  		FIGURE 3. Morphologic analysis of tissue biopsies. A: Surgical biopsies yield intact tissue slices that maintain the fibrotic regions (identified in the inset by the picrosirius red staining) among adipocytes. Arrows show little to no sanguineous regions within the surgical biopsy. B: Needle-aspirated biopsies are more fragmented because of the mechanical stress of this method. Fibrotic regions are not seen; however, sanguineous regions are seen throughout the needle biopsy sample, as indicated with arrows. Staining surgical (C) and needle-aspirated (D) biopsies with HAM56 showed that both methods maintain the crown-like macrophage structures (identified with arrows) observed in obese subjects. These images are illustrative of 3 subjects who were investigated.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Research on human AT is rapidly advancing, and obtaining tissue samples has been greatly facilitated by gastric surgery procedures, which are performed most often in severely obese subjects. However, AT samples are also relatively easy to obtain from lean and obese subjects during elective or programmed surgery (including plastic surgery), thereby permitting comparative AT analyses to be performed in subjects varying in body weight.

Although clinic-based programs have facilitated the access to surgical AT samples, this biopsy method is considerably more laborious and limited in number compared with the "easier to obtain" needle-aspirated biopsy samples. Furthermore, an additional advantage of needle-aspirated biopsies is that they are significantly easier to repeat in the same person throughout the course of a medical or nutritional intervention, thus enabling the measurement of a dynamic individual response to a given intervention (30, 31).

Studies are emerging in which adipose gene expression has been examined in hundreds of subjects simultaneously (32), and it is just a matter of time before such large-scale population studies become routine for the study of human obesity thanks to the rapidly growing number of AT bio-banks around the world. It will be fundamentally important that these studies can be compared so that a common consensus can be reached and potential therapies for human obesity can be postulated. However, there is currently a paucity of information on the comparability of AT microarray data when tissue samples are obtained with the use of different biopsy sampling methods.

Our findings indicate that, although the rapid and more easily obtainable needle-aspirated biopsies can generate data sets that show perturbations in inflammatory and extracellular pathways to a certain degree, they might not capture a comparable overview of the biological changes seen with the more laborious surgical biopsies, especially for the stroma-vascular fraction of AT. The stroma-vascular fraction, which includes components of the extracellular matrix, is now considered important for the study of AT because of its influence on adipocyte cell biology (33–35). In this regard, our immunohistochemistry experiments confirmed that needle-aspirated biopsies are not the optimal method to study the extracellular matrix modifications or the development of fibrosis that can occur in AT and in obesity.

This study shows that it is inappropriate to combine samples obtained by different biopsy techniques for the analysis of AT gene expression within a study. Moreover, we consider that it is absolutely imperative that researchers of future work studying adipose gene expression clearly indicate the sampling methods used, because this will serve to improve the capacity to independently reproduce and compare microarray data. As such, highly authentic and reproducible data from scAT can be generated, ensuring the physiologic relevancy and applicability of all findings and ameliorating our ability to successfully move research in obesity from the bench to the bedside.


   ACKNOWLEDGMENTS
 
We thank Florence Marchelli and Christine Baudoin for contributing to the constitution of the clinical database at the Centre de Recherche en Nutrition Humaine, Ile de France.

The authors' responsibilities were as follows—DMM and KC: designed the study and wrote the paper; DMM, JT, BH, and VP: performed all experimental and statistical work; CH and J-DZ: implemented the FunNet tool and assisted with the analysis; NV and CP: coordinated obtaining subcutaneous adipose tissue samples with the various biopsy techniques; DMM, JT, VP, BH, CH, CP, NV, J-DZ, and KC: read and approved the manuscript. None of the authors had a personal or financial conflict of interest.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Pietilainen, KH, Naukkarinen, J, Rissanen, A, et al.. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008;5: e51:472–83..
  2. Taylor, R. Use of adipose tissue for metabolic studies. Baillieres Clin Endocrinol Metab 1987;1:1023–35..[Medline]
  3. Ashwell, MA, Priest, P & Sowter, C. Importance of fixed sections in the study of adipose tissue cellularity. Nature 1975;256:724–5..[Medline]
  4. Mutch, DM & Clement, K. Unraveling the genetics of human obesity. PLoS Genet 2006;2: e188:1956–63..
  5. Copland, JA, Davies, PJ, Shipley, GL, Wood, CG, Luxon, BA & Urban, RJ. The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Prog Horm Res 2003;58:25–53..[Abstract/Free Full Text]
  6. Lee, YH, Nair, S, Rousseau, E, et al.. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005;48:1776–83..[CrossRef][Medline]
  7. Henegar, C, Tordjman, J, Achard, V, et al.. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 2008;9: R14:1–32..
  8. Clement, K & Langin, D. Regulation of inflammation-related genes in human adipose tissue. J Intern Med 2007;262:422–30..[CrossRef][Medline]
  9. You, T & Nicklas, BJ. Chronic inflammation: role of adipose tissue and modulation by weight loss. Curr Diabetes Rev 2006;2:29–37..[CrossRef][Medline]
  10. Cancello, R, Henegar, C, Viguerie, N, et al.. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277–86..[Abstract/Free Full Text]
  11. Lumeng, CN, Bodzin, JL & Saltiel, AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175–84..[CrossRef][Medline]
  12. Odegaard, JI, Ricardo-Gonzalez, RR, Goforth, MH, et al.. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007;447:1116–20..[CrossRef][Medline]
  13. Kintscher, U, Hartge, M, Hess, K, et al.. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1304–10..[Abstract/Free Full Text]
  14. Lin, SM, Devakumar, J & Kibbe, WA. Improved prediction of treatment response using microarrays and existing biological knowledge. Pharmacogenomics 2006;7:495–501..[CrossRef][Medline]
  15. Golub, TR, Slonim, DK, Tamayo, P, et al.. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531–7..[Abstract/Free Full Text]
  16. Shipp, MA, Ross, KN, Tamayo, P, et al.. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002;8:68–74..[CrossRef][Medline]
  17. Rosenwald, A, Wright, G, Chan, WC, et al.. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937–47..[Abstract/Free Full Text]
  18. van't Veer, LJ, Dai, H, van de Vijver, MK, et al.. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530–6..[CrossRef][Medline]
  19. Mutch, DM, Temanni, MR, Henegar, C, et al.. Adipose gene expression prior to weight loss can differentiate and weakly predict dietary responders. PLoS ONE 2007;2:e1344:1–8..
  20. Clement, K, Viguerie, N, Poitou, C, et al.. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004;18:1657–69..[Abstract/Free Full Text]
  21. Bedossa, P, Lemaigre, G, Bacci, J & Martin, E. Quantitative estimation of the collagen content in normal and pathologic pancreas tissue. Digestion 1989;44:7–13..[Medline]
  22. Hsu, SM, Raine, L & Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–80..[Abstract]
  23. Lemoine, S, Combes, F, Servant, N & Le, CS. Goulphar: rapid access and expertise for standard two-color microarray normalization methods. BMC Bioinformatics 2006;7:467..[CrossRef][Medline]
  24. Saeed, AI, Bhagabati, NK, Braisted, JC, et al.. TM4 microarray software suite. Methods Enzymol 2006;411:134–93..[Medline]
  25. Zhang, Y, Bosse, Y, Marceau, P, et al.. Gene expression variability in subcutaneous and omental adipose tissue of obese men. Gene Expr 2007;14:35–46..[CrossRef][Medline]
  26. Dennis, G, Jr, Sherman, BT, Hosack, DA, et al.. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:3:1–8..[Medline]
  27. Cancello, R, Tordjman, J, Poitou, C, et al.. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006;55:1554–61..[Abstract/Free Full Text]
  28. Padoin, AV, Mottin, CC, Moretto, M, et al.. A comparison of wedge and needle hepatic biopsy in open bariatric surgery. Obes Surg 2006;16:178–82..[Medline]
  29. Kral, JG, Thung, SN, Biron, S, et al.. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48–58..[CrossRef][Medline]
  30. Saris, WH & Harper, A. DiOGenes: a multidisciplinary offensive focused on the obesity epidemic. Obes Rev 2005;6:175–6..[CrossRef][Medline]
  31. Viguerie, N, Vidal, H, Arner, P, et al.. Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005;48:123–31..[CrossRef][Medline]
  32. Emilsson, V, Thorleifsson, G, Zhang, B, et al.. Genetics of gene expression and its effect on disease. Nature 2008;452:423–8..[CrossRef][Medline]
  33. Lacasa, D, Taleb, S, Keophiphath, M, Miranville, A & Clement, K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 2007;148:868–77..[CrossRef][Medline]
  34. Constant, VA, Gagnon, A, Landry, A & Sorisky, A. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 2006;49:1402–11..[CrossRef][Medline]
  35. Suganami, T, Tanimoto-Koyama, K, Nishida, J, et al.. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007;27:84–91..[Abstract/Free Full Text]
Received for publication August 7, 2008. Accepted for publication October 21, 2008.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. Aron-Wisnewsky, J. Tordjman, C. Poitou, F. Darakhshan, D. Hugol, A. Basdevant, A. Aissat, M. Guerre-Millo, and K. Clement
Human Adipose Tissue Macrophages: M1 and M2 Cell Surface Markers in Subcutaneous and Omental Depots and after Weight Loss
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4619 - 4623.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow All Versions of this Article:
89/1/51    most recent
ajcn.2008.26802v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mutch, D. M
Right arrow Articles by Clément, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mutch, D. M
Right arrow Articles by Clément, K.
Agricola
Right arrow Articles by Mutch, D. M
Right arrow Articles by Clément, K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS